These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33384653)

  • 21. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
    Lorenzl S; Buerger K; Hampel H; Beal MF
    Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
    Shukla V; Kumar Shakya A; Dhole TN; Misra UK
    Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases.
    Gardner J; Borgmann K; Deshpande MS; Dhar A; Wu L; Persidsky R; Ghorpade A
    J Neurosci Res; 2006 May; 83(7):1281-92. PubMed ID: 16555295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression.
    Khuth ST; Akaoka H; Pagenstecher A; Verlaeten O; Belin MF; Giraudon P; Bernard A
    J Virol; 2001 Sep; 75(17):8268-82. PubMed ID: 11483772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval.
    Young JW; Kenton JA; Milienne-Petiot M; Deben D; Achim C; Geyer MA; Perry W; Grant IE; Minassian A;
    Behav Brain Res; 2023 Feb; 437():114109. PubMed ID: 36108778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
    Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression.
    Ayoub S; Kenton JA; Milienne-Petiot M; Deben DS; Achim C; Geyer MA; Perry W; Grant IE; Young JW; Minassian A;
    Pharmacol Biochem Behav; 2023 Jan; 222():173499. PubMed ID: 36462584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.
    Zhou J; Marten NW; Bergmann CC; Macklin WB; Hinton DR; Stohlman SA
    J Virol; 2005 Apr; 79(8):4764-73. PubMed ID: 15795262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes.
    Nakai K; Tanaka H; Yamanaka K; Takahashi Y; Murakami F; Matsuike R; Sekino J; Tanabe N; Morita T; Yamazaki Y; Kawato T; Maeno M
    Int J Med Sci; 2017; 14(5):484-493. PubMed ID: 28539825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat
    Cirino TJ; Alleyne AR; Duarte V; Figueroa A; Simons CA; Anceaume EM; Kendrick J; Wallman O; Eans SO; Stacy HM; Medina JM; McLaughlin JP
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):152-164. PubMed ID: 33619645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study.
    Ogier C; Creidy R; Boucraut J; Soloway PD; Khrestchatisky M; Rivera S
    BMC Neurosci; 2005 Nov; 6():68. PubMed ID: 16316466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway.
    Fan Y; Gao X; Chen J; Liu Y; He JJ
    J Neurosci; 2016 Nov; 36(44):11362-11373. PubMed ID: 27807176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease.
    Giraudon P; Szymocha R; Buart S; Bernard A; Cartier L; Belin MF; Akaoka H
    J Immunol; 2000 Mar; 164(5):2718-27. PubMed ID: 10679113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation of matrix metalloproteinase enzyme in HIV-associated neurocognitive disorder.
    Singh H; Nain S; Krishnaraj A; Lata S; Dhole TN
    Gene; 2019 May; 698():41-49. PubMed ID: 30825593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
    Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1.
    Ma C; Tarnuzzer RW; Chegini N
    Wound Repair Regen; 1999; 7(6):477-85. PubMed ID: 10633007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.